Rectify Pharma
Rectify Pharma is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 3 tracked investors.
About Rectify Pharma
Rectify Pharma is a company founded in 2020 headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Rectify Pharma is developing disease-modifying precision therapeutics called Positive Functional Modulators (PFMs) that restore the function of ABC transporter proteins to treat serious genetic diseases affecting organs such as the lungs, liver, GI tract, eye and central nervous system. The company focuses on oral small-molecule modulators to correct loss-of-function mutations in the ABC transporter family.
Explore Rectify Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.